ISSUE 86 I SEPTEMBER 2019

a NEW era of

BUYERS CLUBS

Patients in the UK are banding together to try and get their hands on a generic version of the cystic fibrosis drug Orkambii

Adding value to clinical trial data  

ConcePTION: medication in pregnancy 

Mental health: do the drugs work?

In association with

02/23/2024 23:27:28
  • Home | A new era of buyers clubs
  • TSS AB
  • In this issue
  • NSF
  • Contents
  • Daiichi Jitsugyo
  • News
  • HOF Sonderanlagenbau Company Insight
  • HOF Sonderanlagenbau
  • Capsugel Company Insight
  • The pharma industry briefing
  • ICCI Company Insight
  • ICCI
  • Corbion Purac
  • Real world data: improving clinical trial outcomes
  • Komtur Pharmaceuticals Company Insight
  • Komtur Pharmaceuticals
  • Understanding allergic reactions: chronicling the work of Dr Teruko Ishizaka
  • Scandinavian Health
  • Moehs Iberica SL
  • Swiss WorldCargo
  • Buyers’ clubs: the first step toward universal UK access to Orkambi?
  • TSS Company Insight
  • AtoZ-CRO Company Insight
  • AtoZ-CRO GmbH
  • Prescription dread: measuring psychiatric drugs against the alternatives
  • BEA
  • Zenatek
  • Pfanstiehl
  • Herd health: agriculture’s role in the global AMR crisis
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • Hapa Company Insight
  • ConcePTION: tackling the unknowns of medication in pregnancy
  • AEB Company Insight
  • AEB
  • Pfeiffer Vacuum
  • From start-ups to the SIX Swiss Exchange – a Swiss success story
  • Contract Pharmaceuticals Limited Canada
  • Cancer drug discovery: unravelling the mysteries of halichondrin
  • Centaur Clinical | Company Insight
  • IDMP is back: what next?
  • Charles Ischi
  • Adhesives Research
  • Emirates SkyCargo
  • Global labelling management: why does it continue to cause problems?
  • B&W Tek
  • Events
  • Dali Medical devices
  • Spirax Sarco Company Insight
  • Spirax Sarco
  • Centaur Clinical
  • Next issue
  • Aralab
  • Baxter
08/21/2019 00:00:00